DUGGAN ROBERT W 4

What Happened
Robert W. Duggan, a reported 10% owner of Pulse Biosciences (PLSE), was awarded two derivative grants on 2026-06-11 totaling 42,495 shares (30,000 and 12,495). The grants are reported at $0.00 (derivative award) and will vest over the coming year per the filing. This was an award/acquisition (not a market purchase or sale).

Key Details

• Transaction date: 2026-06-11; Reported filing date: 2026-06-15 (appears timely under the two-business-day rule).
• Reported price: $0.00 for both awards (derivative).
• Total shares awarded: 42,495 (30,000 + 12,495).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Footnotes:
  • F1: The 30,000-share award vests in equal monthly installments over one year, first vesting on July 11, 2026.
  • F2: The 12,495-share award vests in equal quarterly installments over one year, first vesting on September 5, 2026.
• Transaction code: A (award/grant/other acquisition). No 10b5-1 plan or tax-withholding detail disclosed.

Context
These are derivative awards that vest over time (per footnotes); they are not immediate cashless exercises or open-market purchases/sales. As a 10% owner, Duggan is a substantial holder—this filing documents an internal grant rather than an immediate market-driven trade. For retail investors, awards signal potential future share issuance when vested, but do not by themselves indicate current buying or selling sentiment.